Why the study?
Do 5-HT2 receptor antagonists reduce myocardial damage in isolated ischemic rat hearts?
Do 5-HT2 receptor antagonists reduce myocardial damage in isolated ischemic rat hearts?
5-HT2 receptor antagonists provide cardioprotection against ischemic injury in isolated rat hearts, suggesting serotonin exacerbates myocardial damage via 5-HT2 receptors.
Answers are grounded in this paper and cite their sources.
Supports 5-HT2 antagonism for ischemic cardioprotection in rats; leaves open clinical translation to human myocardial infarction.
Serotonin (5-HT) may play a role in exacerbating thrombosis and coronary spasm during myocardial ischemia, but its role in mediating myocardial damage directly is not clear. We determined the effect of the 5-HT2 receptor antagonists cinanserin (0.1-10 microM), ketanserin (0.3-10 microM), and LY 53857 (1-10 microM) on time to contracture, recovery of contractile function, and lactate dehydrogenase (LDH) release after 25-min global ischemia and 30-min reperfusion in isolated rat heart. All 5-HT2 antagonists significantly increased time to contracture in a concentration-dependent manner (EC25 = 1.6, 5.5, and 6.1 microM for cinanserin, ketanserin, and LY 53857, respectively). These compounds also significantly reduced LDH release and improved recovery of contractile function during reperfusion. 5-HT > or = 30 microM significantly reduced time to contracture, indicating a proischemic effect. The proischemic effect of 5-HT was abolished by ketanserin and cinanserin. Inhibition of 5-HT synthesis by parachlorophenylalanine resulted in significant cardioprotection, further indicating the involvement of 5-HT in the pathogenesis of ischemia in this model. Although cinanserin and ketanserin had alpha 1-adrenoceptor blocking effects, LY 53857 was devoid of this activity at concentrations exhibiting cardioprotection. Therefore, 5-HT may exacerbate ischemic injury in rat heart, and this exacerbation appears to be mediated specifically by 5-HT2 receptors.
No takes yet. Share an insight, caveat, or question.
Grover et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: